+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proton Pump Inhibitors (PPIs) Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5547261
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The proton pump inhibitors (PPIs) market is forecasted to grow by USD 807.89 mn during 2023-2028, accelerating at a CAGR of 4.86% during the forecast period. The report on the proton pump inhibitors (PPIs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reformulation of drugs, growth in prescription rate, and strong prevalence of gastroesophageal reflux disease.

The proton pump inhibitors (PPIs) market is segmented as below:

By Product

  • OTC PPIs
  • Prescription PPIs

By Route Of Administration

  • Oral
  • Injectable

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing geriatric population as one of the prime reasons driving the proton pump inhibitors (PPIs) market growth during the next few years. Also, rising prevalence of obesity and personalized PPI therapy will lead to sizable demand in the market.

The report on the proton pump inhibitors (PPIs) market covers the following areas:

  • Proton pump inhibitors (PPIs) market sizing
  • Proton pump inhibitors (PPIs) market forecast
  • Proton pump inhibitors (PPIs) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proton pump inhibitors (PPIs) market vendors that include Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd.. Also, the proton pump inhibitors (PPIs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global proton pump inhibitors (PPIs) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 OTC PPIs - Market size and forecast 2023-2028
Exhibit 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
6.4 Prescription PPIs - Market size and forecast 2023-2028
Exhibit 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
Exhibit 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Injectable - Market size and forecast 2023-2028
Exhibit 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 107: Amgen Inc. - Overview
Exhibit 108: Amgen Inc. - Product/Service
Exhibit 109: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 110: AstraZeneca Plc - Overview
Exhibit 111: AstraZeneca Plc - Product/Service
Exhibit 112: AstraZeneca Plc - Key news
Exhibit 113: AstraZeneca Plc - Key offerings
12.5 Aurobindo Pharma Ltd.
Exhibit 114: Aurobindo Pharma Ltd. - Overview
Exhibit 115: Aurobindo Pharma Ltd. - Product/Service
Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
12.6 Bausch Health Companies Inc.
Exhibit 117: Bausch Health Companies Inc. - Overview
Exhibit 118: Bausch Health Companies Inc. - Business segments
Exhibit 119: Bausch Health Companies Inc. - Key news
Exhibit 120: Bausch Health Companies Inc. - Key offerings
Exhibit 121: Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Eisai Co. Ltd.
Exhibit 131: Eisai Co. Ltd. - Overview
Exhibit 132: Eisai Co. Ltd. - Business segments
Exhibit 133: Eisai Co. Ltd. - Key offerings
Exhibit 134: Eisai Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Exhibit 135: Eli Lilly and Co. - Overview
Exhibit 136: Eli Lilly and Co. - Product/Service
Exhibit 137: Eli Lilly and Co. - Key news
Exhibit 138: Eli Lilly and Co. - Key offerings
12.11 Glenmark Pharmaceuticals Ltd.
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 Pfizer Inc.
Exhibit 142: Pfizer Inc. - Overview
Exhibit 143: Pfizer Inc. - Product/Service
Exhibit 144: Pfizer Inc. - Key news
Exhibit 145: Pfizer Inc. - Key offerings
12.13 Sun Pharmaceutical Industries Ltd.
Exhibit 146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 147: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibit 148: Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Takeda Pharmaceutical Co. Ltd.
Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 152: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.15 Teva Pharmaceutical Industries Ltd.
Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 The Procter and Gamble Co.
Exhibit 158: The Procter and Gamble Co. - Overview
Exhibit 159: The Procter and Gamble Co. - Business segments
Exhibit 160: The Procter and Gamble Co. - Key news
Exhibit 161: The Procter and Gamble Co. - Key offerings
Exhibit 162: The Procter and Gamble Co. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 163: Zydus Lifesciences Ltd. - Overview
Exhibit 164: Zydus Lifesciences Ltd. - Business segments
Exhibit 165: Zydus Lifesciences Ltd. - Key offerings
Exhibit 166: Zydus Lifesciences Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global proton pump inhibitors (ppis) market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on OTC PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on OTC PPIs - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Prescription PPIs - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Prescription PPIs - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Route of Administration
Exhibits 47: Data Table on Comparison by Route of Administration
Exhibits 48: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Route of Administration ($ million)
Exhibits 57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Amgen Inc. - Overview
Exhibits 108: Amgen Inc. - Product/Service
Exhibits 109: Amgen Inc. - Key offerings
Exhibits 110: AstraZeneca Plc - Overview
Exhibits 111: AstraZeneca Plc - Product/Service
Exhibits 112: AstraZeneca Plc - Key news
Exhibits 113: AstraZeneca Plc - Key offerings
Exhibits 114: Aurobindo Pharma Ltd. - Overview
Exhibits 115: Aurobindo Pharma Ltd. - Product/Service
Exhibits 116: Aurobindo Pharma Ltd. - Key offerings
Exhibits 117: Bausch Health Companies Inc. - Overview
Exhibits 118: Bausch Health Companies Inc. - Business segments
Exhibits 119: Bausch Health Companies Inc. - Key news
Exhibits 120: Bausch Health Companies Inc. - Key offerings
Exhibits 121: Bausch Health Companies Inc. - Segment focus
Exhibits 122: Bayer AG - Overview
Exhibits 123: Bayer AG - Business segments
Exhibits 124: Bayer AG - Key news
Exhibits 125: Bayer AG - Key offerings
Exhibits 126: Bayer AG - Segment focus
Exhibits 127: Dr Reddys Laboratories Ltd. - Overview
Exhibits 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 131: Eisai Co. Ltd. - Overview
Exhibits 132: Eisai Co. Ltd. - Business segments
Exhibits 133: Eisai Co. Ltd. - Key offerings
Exhibits 134: Eisai Co. Ltd. - Segment focus
Exhibits 135: Eli Lilly and Co. - Overview
Exhibits 136: Eli Lilly and Co. - Product/Service
Exhibits 137: Eli Lilly and Co. - Key news
Exhibits 138: Eli Lilly and Co. - Key offerings
Exhibits 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 140: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibits 141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 142: Pfizer Inc. - Overview
Exhibits 143: Pfizer Inc. - Product/Service
Exhibits 144: Pfizer Inc. - Key news
Exhibits 145: Pfizer Inc. - Key offerings
Exhibits 146: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 147: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 148: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 149: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 150: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibits 151: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 152: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 153: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 154: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 155: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 156: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 157: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 158: The Procter and Gamble Co. - Overview
Exhibits 159: The Procter and Gamble Co. - Business segments
Exhibits 160: The Procter and Gamble Co. - Key news
Exhibits 161: The Procter and Gamble Co. - Key offerings
Exhibits 162: The Procter and Gamble Co. - Segment focus
Exhibits 163: Zydus Lifesciences Ltd. - Overview
Exhibits 164: Zydus Lifesciences Ltd. - Business segments
Exhibits 165: Zydus Lifesciences Ltd. - Key offerings
Exhibits 166: Zydus Lifesciences Ltd. - Segment focus
Exhibits 167: Inclusions checklist
Exhibits 168: Exclusions checklist
Exhibits 169: Currency conversion rates for US$
Exhibits 170: Research methodology
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Information sources
Exhibits 173: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global proton pump inhibitors (PPIs) market: Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is growing geriatric population.'

According to the report, one of the major drivers for this market is the reformulation of drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • Glenmark Pharmaceuticals Ltd.
  • Johnson and Johnson
  • Perrigo Co. Plc
  • Pfizer Inc.
  • RedHill Biopharma Ltd.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • The Procter and Gamble Co.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Proton Pump Inhibitors Global Market Report 2024 - Product Image

Proton Pump Inhibitors Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Proton Pump Inhibitors (PPIs) - Global Strategic Business Report - Product Image

Proton Pump Inhibitors (PPIs) - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
Geriatric Medicine Market Size, Share & Trends Analysis Report By Therapeutics (Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors), By Condition, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Geriatric Medicine Market Size, Share & Trends Analysis Report By Therapeutics (Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors), By Condition, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Duodenal Ulcer Treatment Market Size, Share and Trends Analysis Report by Treatment (Proton Pump Inhibitors, H2 Antagonists), Route of Administration (Oral, Parenteral), Distribution Channel (Retail Pharmacies), and Region 2024-2030 - Product Image

Duodenal Ulcer Treatment Market Size, Share and Trends Analysis Report by Treatment (Proton Pump Inhibitors, H2 Antagonists), Route of Administration (Oral, Parenteral), Distribution Channel (Retail Pharmacies), and Region 2024-2030

  • Report
  • 90 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.